Merck & Co., Inc. (BIT:1MRKX)

Italy flag Italy · Delayed Price · Currency is EUR
92.60
-0.20 (-0.22%)
Last updated: Jan 20, 2026, 10:00 AM CET
-2.83%
Market Cap235.79B
Revenue (ttm)54.75B
Net Income (ttm)16.22B
Shares Outn/a
EPS (ttm)6.44
PE Ratio14.53
Forward PE19.74
Dividend1.44 (1.52%)
Ex-Dividend DateSep 12, 2025
Volume47
Average Volume294
Open92.60
Previous Close92.80
Day's Range92.60 - 92.60
52-Week Range65.40 - 96.50
Betan/a
RSI64.69
Earnings DateFeb 3, 2026

About Merck & Co.

Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M−M−R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, B... [Read more]

Industry Pharmaceutical Preparations
Founded 1891
Employees 75,000
Stock Exchange Borsa Italiana
Ticker Symbol 1MRKX
Full Company Profile

Financial Performance

In 2024, Merck & Co.'s revenue was $64.17 billion, an increase of 6.74% compared to the previous year's $60.12 billion. Earnings were $17.12 billion, an increase of 4589.59%.

Financial numbers in USD Financial Statements